Related Experiment Videos
[Experience with the depot neuroleptic LyogenR-depot]
Psychiatrie, Neurologie, Und Medizinische Psychologie
|September 1, 1978
Summary
Lyogen Depot significantly reduced relapses in schizophrenic psychoses outpatient aftertreatment. Systematic inclusion in dispensary treatment schemes maximized positive outcomes for patients with schizophrenia.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Context:
- Schizophrenic psychoses represent a significant public health challenge requiring effective long-term management strategies.
- Outpatient aftertreatment is crucial for maintaining remission and improving the quality of life for individuals with schizophrenia.
Purpose:
- To evaluate the efficacy of Lyogen Depot in reducing relapse rates among schizophrenic patients undergoing outpatient aftertreatment.
- To assess the overall impact of Lyogen Depot on the management of schizophrenic psychoses within a dispensary treatment framework.
Summary:
- Lyogen Depot administration in outpatient aftertreatment of schizophrenic psychoses led to a highly significant reduction in relapse frequency.
- The effectiveness of Lyogen Depot was particularly pronounced when patients were systematically integrated into dispensary treatment programs.
Impact:
- The findings suggest Lyogen Depot is a valuable therapeutic option for preventing relapses in schizophrenia, improving patient outcomes.
- Systematic patient enrollment in treatment schemes enhances the positive impact of Lyogen Depot, optimizing care for schizophrenic populations.